 I think over time, as the population got stronger, and when I say stronger, I mean from an immune perspective, in terms of immune protection with bouts of infection and of vaccinations, we're finding that in this era that Paxlovid probably gives the biggest bang for the buck in those who are older than 65 and those who are immune compromised, you know, barring drug interactions.